ozone exposure increases red blood cell antioxidant enzyme activity by up to 36%
Ozone therapy in ARMD patients increased total RBC G6PDH activity from 356.8 ± 90.7 to 406.2 ± 40.4 nmoles/h/mg Hb, and young RBC G6PDH activity from 550.3 ± 157.5 to 748.2 ± 181.9 nmoles/h/mg Hb after 13 treatments.
What this means for you
G6PDH is a key enzyme your red blood cells use to protect themselves from oxidative damage. When its activity rises, your blood cells become more resilient — which supports better oxygen delivery, less cellular wear-and-tear, and the kind of low-level recovery your body is doing quietly in the background every day.
The published research
DOES OZONETHERAPY HAVE A FUTURE IN MEDICINE ?
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.